BridgeMD
New treatment option for Machine Learning
Official title Timely Ordering of Pharmacogenetic Testing
ClinicalTrials.gov ID: NCT06902688
What this study is testing
- What it's testing
- The goal of this trial is to learn if a machine learning (ML) model can help optimize drug therapy in the pediatric population. The main question(s) it aims to answer are whether a machine learning model predicting receipt of a targeted medication within the next three months: Increases the offering of pharmacogenetic testing prior to receipt of a targeted medication Increases the number of patients with pharmacogenetic results prior to receipt of a targeted medication Increases the number of patients who have alteration in medication choice or dose based on pharmacogenetic results This trial only focuses on the prediction and provision of participants with a high-risk of receiving a medication with a pharmacogenetic indication in the next three months.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 18
You may be able to join if
- Inpatient at The Hospital for Sick Children
- Between 6 months to 18 years old
You likely can't join if
- Prior pharmacogenetic testing and/or prior receipt of a targeted medication
- Current Intensive Care Unit (ICU) admission
- Expected hospital discharge is prior to midnight on the day of admission
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 months to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.